143 related articles for article (PubMed ID: 36459061)
21. Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study.
Sarzani R; Allevi M; Giulietti F; Sarnari S; Scorcella S; Di Agostini A; Turri P; Di Pentima C; Spannella F
Nutr Metab Cardiovasc Dis; 2024 Jan; 34(1):136-144. PubMed ID: 37798232
[TBL] [Abstract][Full Text] [Related]
22. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
[TBL] [Abstract][Full Text] [Related]
23. Are Chronic Pain Syndromes the Reason for Statin-associated Muscle Symptoms?
Sheinin R; Nogueira AR; Bragazzi NL; Watad A; Tiosano S; Gonen T; Sharif K; Kameri Y; Amital H; Amital D; Cohen H
Isr Med Assoc J; 2022 Nov; 24(11):719-726. PubMed ID: 36436038
[TBL] [Abstract][Full Text] [Related]
24. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.
Wei MY; Ito MK; Cohen JD; Brinton EA; Jacobson TA
J Clin Lipidol; 2013; 7(5):472-83. PubMed ID: 24079289
[TBL] [Abstract][Full Text] [Related]
25. Update on SAMS: Statin-associated muscle symptoms.
Stock JK
Atherosclerosis; 2018 Feb; 269():260-261. PubMed ID: 29361270
[No Abstract] [Full Text] [Related]
26. Effect of statin treatment on metabolites, lipids and prostanoids in patients with Statin Associated Muscle Symptoms (SAMS).
Garrett TJ; Puchowicz MA; Park EA; Dong Q; Farage G; Childress R; Guingab J; Simpson CL; Sen S; Brogdon EC; Buchanan LM; Raghow R; Elam MB
PLoS One; 2023; 18(12):e0294498. PubMed ID: 38100464
[TBL] [Abstract][Full Text] [Related]
27. Statin-associated muscle symptoms-Managing the highly intolerant.
Backes JM; Ruisinger JF; Gibson CA; Moriarty PM
J Clin Lipidol; 2017; 11(1):24-33. PubMed ID: 28391891
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain.
Pennisi M; Di Bartolo G; Malaguarnera G; Bella R; Lanza G; Malaguarnera M
Dis Markers; 2019; 2019():3549402. PubMed ID: 31019583
[TBL] [Abstract][Full Text] [Related]
29. Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching.
Lohia P; Kapur S; Benjaram S; Mir T
J Clin Lipidol; 2021; 15(3):451-459. PubMed ID: 33726984
[TBL] [Abstract][Full Text] [Related]
30. COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population.
Hubacek JA; Adamkova V; Zlatohlavek L; Steiner-Mrazova L; Vrablik M
Drug Metab Pers Ther; 2017 Dec; 32(4):177-182. PubMed ID: 29257754
[TBL] [Abstract][Full Text] [Related]
31. Clinical features related to statin-associated muscle symptoms.
Ochs-Balcom HM; Nguyen LM; Ma C; Isackson PJ; Luzum JA; Kitzmiller JP; Tarnopolsky M; Weisman M; Christopher-Stine L; Peltier W; Wortmann RL; Vladutiu GD
Muscle Nerve; 2019 May; 59(5):537-543. PubMed ID: 30549046
[TBL] [Abstract][Full Text] [Related]
32. Development and Application of Pharmacological Statin-Associated Muscle Symptoms Phenotyping Algorithms Using Structured and Unstructured Electronic Health Records Data.
Sun B; Yew PY; Chi CL; Song M; Loth M; Zhang R; Straka RJ
medRxiv; 2023 May; ():. PubMed ID: 37215024
[TBL] [Abstract][Full Text] [Related]
33. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
[TBL] [Abstract][Full Text] [Related]
34. Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial.
Kristiansen O; Vethe NT; Peersen K; Wang Fagerland M; Sverre E; Prunés Jensen E; Lindberg M; Gjertsen E; Gullestad L; Perk J; Dammen T; Bergan S; Husebye E; Otterstad JE; Munkhaugen J
Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):507-516. PubMed ID: 32609361
[TBL] [Abstract][Full Text] [Related]
35. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
[No Abstract] [Full Text] [Related]
36. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2019 Mar; 4(3):206-213. PubMed ID: 30758506
[TBL] [Abstract][Full Text] [Related]
37. Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
Brennan ET; Joy TR
Can J Cardiol; 2017 May; 33(5):666-673. PubMed ID: 28449837
[TBL] [Abstract][Full Text] [Related]
38. Comparison of adherence, persistence, and clinical outcome of generic and brand-name statin users: A retrospective cohort study using the Japanese claims database.
Gao J; Seki T; Kawakami K
J Cardiol; 2021 May; 77(5):545-551. PubMed ID: 33371973
[TBL] [Abstract][Full Text] [Related]
39. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
[TBL] [Abstract][Full Text] [Related]
40. Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis.
Lemstra M; Blackburn D; Crawley A; Fung R
Can J Cardiol; 2012; 28(5):574-80. PubMed ID: 22884278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
